A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)
NCT00644358
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
616
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
vilazodone
Sponsor
Forest Laboratories